Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BMS-986449 |
Synonyms | |
Therapy Description |
Limited information is currently available on BMS-986449 (Jun 2023). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
BMS-986449 | BMS 986449|BMS986449 | Limited information is currently available on BMS-986449 (Jun 2023). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05888831 | Phase Ib/II | BMS-986449 + Nivolumab BMS-986449 | A Study of BMS-986449 With and Without Nivolumab in Participants With Advanced Solid Tumors | Recruiting | USA | NLD | ITA | FRA | ESP | BEL | 0 |